-
Nov 08, 10 FDA Approvals
Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain,… »
Nov 08, 10 Clinical UpdatesA closely watched experimental drug for rheumatoid arthritis being developed by Pfizer Inc significantly reduced symptoms and improved physical function,… »
Nov 08, 10 Clinical UpdatesA new study suggests joint complaints attributed to aromatase inhibitors (AI), popular breast cancer drugs, are not associated with inflammatory… »
Nov 05, 10 FDA warningsUsing high doses of Novo Nordisk’s anti-clotting medicine to treat dangerous bleeding in non-hemophiliacs may raise the risk of heart… »
Nov 05, 10 Clinical UpdatesSpending more on drugs does not always translate into healthier patients, U.S. researchers reported on Wednesday.
And in a second… »
Nov 05, 10 Clinical UpdatesNanoparticles could help smuggle drugs into the gut, according to a study published this month in the International Journal of… »
Nov 04, 10 Clinical UpdatesA new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple… »
Nov 03, 10 Drug NewsDavid Henry discusses a recent research article in PLoS Medicine that suggests that relationships between doctors and drug companies are… »
Nov 03, 10 Clinical UpdatesIn adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less… »
Nov 02, 10 Clinical UpdatesAn initiative by the U. S. technology company Pitney Bowes to make medications of proven value less expensive for their… »
Subscribe to the "News" RSS Feed
TOP ۞